Share-based Payment Arrangement, Expense of ACTUATE THERAPEUTICS, INC. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ACTUATE THERAPEUTICS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • ACTUATE THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,800,614, a 218% increase year-over-year.
  • ACTUATE THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $5,696,573.
  • ACTUATE THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $1,995,793, a 371% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ACTUATE THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,696,573 $1,800,614 +$1,234,633 +218% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $4,461,940 $1,579,271 +$1,489,252 +1654% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $2,972,688 $1,125,101 +$976,895 +659% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $1,995,793 $1,191,587 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $565,981 +$410,754 +265% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $90,019 +$16,888 +23% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $148,206 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q3 2023 $155,227 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $73,131 01 Apr 2023 30 Jun 2023 10-Q 24 Sep 2024 2024 Q2

ACTUATE THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,995,793 +$1,572,254 +371% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $423,539 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.